Although lipid oxidation products are usually associated with tissue injury
, it is now recognized that they can also contribute to cell activation and
elicit antiinflammatory lipid mediators. In this study, we report that mem
brane phospholipid oxidation can modulate the hemostatic balance. Oxidation
of natural phospholipids results in an increased ability of the membrane s
urface to support the function of the natural anticoagulant, activated prot
ein C (APC), without significantly altering the ability to support thrombin
generation. Lipid oxidation also potentiated the ability of protein S to e
nhance APC-mediated factor Va inactivation. Phosphatidylethanolamine, phosp
hatidylserine, and polyunsaturation of the fatty acids were all required fo
r the oxidation-dependent enhancement of APC function. A subgroup of thromb
otic patients with anti-phospholipid antibodies specifically blocked the ox
idation-dependent enhancement of APC function. Since leukocytes are recruit
ed and activated at the thrombus or sites of vessel injury, our findings su
ggest that after the initial thrombus formation, lipid oxidation can remode
l the membrane surface resulting in increased anticoagulant function, there
by reducing the thrombogenicity of the thrombus or injured vessel surface.
Anti-phospholipid antibodies that block this process would therefore be exp
ected to contribute to thrombus growth and disease.